REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
REYON Pharmaceutical Dividend Announcement
• REYON Pharmaceutical announced a annually dividend of ₩150.00 per ordinary share which will be made payable on 2024-04-23. Ex dividend date: 2023-12-27
• REYON Pharmaceutical annual dividend for 2023 was ₩150.00
• REYON Pharmaceutical's trailing twelve-month (TTM) dividend yield is 0.92%
• REYON Pharmaceutical's payout ratio for the trailing twelve months (TTM) is -2633.58%
• REYON Pharmaceutical's dividend growth over the last five years (2018-2023) was -21.09% year
• REYON Pharmaceutical's dividend growth over the last ten years (2013-2023) was 2.86% year
REYON Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-12-27 | ₩150.00 | annually | 2024-04-23 |
2022-12-28 | ₩150.00 | annually | 2023-04-21 |
2021-12-29 | ₩250.00 | annually | 2022-04-25 |
2020-12-29 | ₩200.00 | annually | 2021-04-23 |
2019-12-27 | ₩343.14 | annually | 2020-04-17 |
2018-12-27 | ₩490.20 | annually | 2019-04-16 |
2017-12-27 | ₩343.14 | annually | 2018-04-19 |
2016-12-28 | ₩263.95 | annually | |
2015-12-29 | ₩226.24 | annually | |
2014-12-29 | ₩188.54 | annually | |
2013-12-27 | ₩113.12 | annually | |
2012-12-27 | ₩150.83 | annually |
REYON Pharmaceutical Dividend per year
REYON Pharmaceutical Dividend growth
REYON Pharmaceutical Dividend Yield
REYON Pharmaceutical current trailing twelve-month (TTM) dividend yield is 0.92%. Interested in purchasing REYON Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
REYON Pharmaceutical Financial Ratios
REYON Pharmaceutical Dividend FAQ
Other factors to consider when evaluating REYON Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy REYON Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: REYON Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, REYON Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, REYON Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from REYON Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: REYON Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, REYON Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: REYON Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of REYON Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review REYON Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.